Phacoemulsification, PC-IOL Implantation, and Posterior Lamellar Corneal Transplant in Eye With Hard Cataract and Severe Bullous Keratopathy

Eyetube

This video presents a combined procedure for the surgical treatment of a mature, hard nucleus cataract and severe bullous keratopathy. Ozana Moraru, MD, highlights the difficulties of working in poor visibility conditions and the chop technique for a brown cataract, followed by the hydro-implantation of a posterior chamber IOL and the insertion of the DSAEK lamella.

The Premium IOL Market Is Accelerating

What this means for cataract surgeons.

Wayne Caulder

Cataract and Refractive Surgery Today

Leading ophthalmic practices must embrace innovation to stay competitive. Adopting cutting-edge solutions such as premium IOLs can enhance patient outcomes and reinforce a practice’s commitment to excellence. Wayne Caulder is a trailblazer in ophthalmology whose pioneering work has helped shape patient care and surgical practices. The insights he shares in this article underscore the importance of embracing change and striving for excellence in a competitive landscape. Tracy J. Kenniff, MBA, OCS Premium IOLs have moved from the margins of cataract surgery into the mainstream of modern ophthalmic practice. What was once a niche offering is now a core growth engine for practices across the United States and a meaningful driver of patient satisfaction, practice differentiation, and long-term sustainability. Understanding why this market is expanding and how to respond thoughtfully is essential for any surgeon focused on the future. A MARKET POISED FOR CONTINUED GROWTH The United States is, by far, the largest premium cataract surgery market in the world; it accounts for approximately 36% of global manufacturer revenue.1 Of the estimated 5.2 million cataract and refractive lens exchange procedures that were expected in 2025, Market Scope projected that roughly 38%—or about 1.98 million cases—would include at least one premium component.1 Several factors explain why the US market has reached this scale. First, the country has a large and relatively affluent patient population with high expectations for visual performance.

Scleral Buckling

Eyetube

Using Imaging to Understand the Causes and Sequelae of Hypotony

A- and B-scan ultrasound, ultrasound biomicroscopy, and OCT can be crucial for diagnosis and management.

Poojitha Balakrishnan, MD, MPH, PhD, and Jithin Yohannan, MD, MPH

Glaucoma Today

Key Takeaways Hypotony is a significant complication of glaucoma surgery, frequently observed following filtering surgery. Identifying the causes and sequelae of hypotony can be a challenge with slit-lamp examinations and indirect ophthalmoscopy alone. Imaging modalities such as OCT, A- and B-scan ultrasound, and ultrasound biomicroscopy may be valuable complementary tools for diagnosing and managing hypotony. Hypotony (IOP < 5–6 mm Hg) may be a significant complication of glaucoma surgery and is most frequently observed during the postoperative period, particularly following filtering surgery. Although the condition is often visually insignificant and/or transient, persistent and visually significant hypotony can lead to adverse outcomes. Clinically significant hypotony may induce neurosensory retinal and structural alterations, potentially resulting in irreversible visual impairment.1,2

Continuing the Dry Eye Conversation

Jackie Garlich, OD, FAAO and Jessilin Quint, OD, FAAO

Eyetube

Kicking off the first episode of the To the Point podcast in 2026, co-hosts Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, FAAO, continue the dry eye conversation with DED pearls to implement in clinic. They cover everything from patient signs, symptoms, and side effects to in-office tools, treatments, and therapeutics and OTC options.

More than 3 Million Bottles of Eye Drops Recalled

Eyetube

A major recall is announced for several store-brand OTC eye drops; the FDA extends dosing intervals for Eylea HD in patients with Wet AMD and DME; and Bausch + Lomb launches its second full range of vision IOL in Europe. Learn more about your ad choices. Visit megaphone.fm/adchoices

Unlock Your Leadership Potential: See and Inspire Beyond the Lens

Highlights from a recent YoungOD Connect mentoring session.

Tom Chwe, OD, Dipl ABO

Modern Optometry

All doctors are leaders in some form or fashion. We are charged with inspiring our patients, and we have technicians and ancillary staff who work with us to provide quality patient care. Whether we’re employed or have a practice of our own, we as doctors of optometry have the ability to influence the people with whom we come into contact. If we understand how to harness the power we have, we can create big changes whether as a practice owner or an associate optometrist. MY PATH TO OPTOMETRY I grew up in Canada, and when I was 16, I went to the DMV to get my license. I took the vision screening test, and they told me I wasn’t getting my license that day because I couldn’t see some of the letters, which was a shock to me. I was a very low myope and didn’t realize it. I had to schedule an appointment with an optometrist, and when I tried on my first pair of glasses, I realized I had not been seeing well before then. Going through that whole experience with my optometrist—I knew at that point that’s what I wanted to do. So, I completed my undergraduate studies at the University of Waterloo and then attended the Southern College of Optometry in Memphis, where I graduated in 2010.

Use of the Streamline Clear Device

I. Paul Singh, MD

Eyetube

In this video, I. Paul Singh, MD, demonstrates use of the Streamline Surgical System (New World Medical) with a clear tip to aid visualization. Financial Disclosure: Consultant (New World Medical)

AI Beyond the Clinic

Cathleen M. McCabe, MD; and Sean Ianchulev, MD, MPH

Eyetube

Cathleen McCabe, MD, speaks with Sean Ianchulev, MD, MPH, about his recent article in CRST’s January issue, “AI Beyond the Clinic,” which provides a deep dive on how regulation and reimbursement accelerate AI and home monitoring beyond exam lanes and into patients' homes. Dr. Ianchulev shares insights into where AI currently impacts his clinic and the innovation he implements to elevate patient care. Related perspectives appear in the January issue of CRST.

How To Increase Diversity on the Podium

Who is presenting matters; it shapes the profession and the aspirations of trainees.

Melissa Yuan, MD; Eugenia C. Greig, MD; and Carolyn K. Pan, MD

Retina Today

Key Takeaways From 2015 to 2019, women filled 22.1% of faculty positions at retina meetings. As of 2025, women comprised 36.6% of meeting faculty, representing meaningful progress toward proportional representation. Meetings with at least one woman on the program committee are significantly more likely to include female non-paper presenters, moderators or panelists, and total women faculty. Patients from underserved backgrounds are more likely to seek care from providers that share a similar culture, and providers from underserved backgrounds are more likely to serve the communities they represent. Diverse representation in leadership roles enriches scientific discourse, challenges assumptions, and delivers equitable patient care. The composition of speakers, moderators, and panelists at medical conferences serves as both a mirror and a catalyst for our specialty. These visible leadership roles reflect who holds influence in the field and shape the aspirations of trainees and early-career ophthalmologists. In retina, as in many specialties, achieving representative diversity on the podium and in the field has been a slow journey.1 However, recent data suggest we may be reaching an inflection point. CLOSING THE GAP WITH INTENTION Based on the current American Society of Retina Specialists (ASRS) membership data, women represent approximately 20% of regular ASRS members.2 A comprehensive analysis of retina meetings from 2015 to 2019 by Sridhar et al examined 4,521 faculty roles and found that women filled 22.1% of those positions, with a significant increase within those years.3 We reviewed recent data from retina meetings in 2025 to provide a present-day snapshot and determine if the number of women on the podium has continued to grow. The meetings included in this analysis were AAO Retina Subspecialty Day, ASRS, Retina Society, Macula Society, Vit-Buckle Society, Aspen Retinal Detachment Society (note that ARDS 2024 data is used instead of 2025, as the 2025 meeting minutes were not yet available).